[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Norin, 2007 - Google Patents

Coordination Chemistry of Novel Drug Candidates for the Treatment of Iron Overload

Norin, 2007

View PDF
Document ID
7014213933115323825
Author
Norin A
Publication year

External Links

Snippet

Iron overload is a serious clinical condition caused by excessive iron in the body, which can be largely prevented by the use of iron-specific chelating agents. At the moment there are only a few chelators in clinical use for the treatment of Fe overload. One of them, and so far …
Continue reading at www.diva-portal.org (PDF) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with heteroatoms or with carbon atoms having three bonds to hetero atoms, with at the most one to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System
    • C07F15/06—Cobalt compounds
    • C07F15/065—Cobalt compounds without a metal-carbon linkage
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System
    • C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System compounds of the platinum group
    • C07F15/0086—Platinum compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System
    • C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System compounds of the platinum group
    • C07F15/0073—Rhodium compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F13/00—Compounds containing elements of Groups 7 or 17 of the Periodic System
    • C07F13/005—Compounds without a metal-carbon linkage
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System
    • C07F15/02—Iron compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F19/00—Metal compounds according to more than one of main groups C07F1/00 - C07F17/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F17/00—Metallocenes
    • C07F17/02—Metallocenes of metals of Groups 8, 9 or 10 of the Periodic System

Similar Documents

Publication Publication Date Title
Singh et al. In vitro and in vivo antitumour studies of a new thiosemicarbazide derivative and its complexes with 3d-metal ions
Bernhardt et al. Iron chelators of the dipyridylketone thiosemicarbazone class: precomplexation and transmetalation effects on anticancer activity
Woo et al. Vanadyl–biguanide complexes as potential synergistic insulin mimics
CA2382105C (en) Substituted pyridino pentaazamacrocyle complexes having superoxide dismutase activity
AU737650B2 (en) Substituted porphyrins
Zhang et al. Lipophilic coordination compounds: aluminum, gallium, and indium complexes of 1-aryl-3-hydroxy-2-methyl-4-pyridinones
Nkabyo et al. Recent advances in the coordination and supramolecular chemistry of monopodal and bipodal acylthiourea-based ligands
AU780118B2 (en) Peroxynitrite decomposition catalysts and methods of use thereof
Crans et al. Vanadium (IV) and vanadium (V) complexes of dipicolinic acid and derivatives. Synthesis, X-ray structure, solution state properties: and effects in rats with STZ-induced diabetes
Basha et al. Heterocyclic dithiocarbazate iron chelators: Fe coordination chemistry and biological activity
Calamai et al. Biological properties of two gold (III) complexes: AuCl3 (Hpm) and AuCl2 (pm)
Bernhardt et al. Hydrazone chelators for the treatment of iron overload disorders: iron coordination chemistry and biological activity
Beissel et al. Mono-and dinuclear transition metal complexes of the hexadentate ligand tris (4-tert-butyl-2-mercaptobenzyl)-1, 4, 7-triazacyclononane (L)
US8334377B2 (en) Porphyrin catalysts and methods of use thereof
Sahu et al. Dithiocarbazate based oxidomethoxidovanadium (V) and mixed-ligand oxidovanadium (IV) complexes: Study of solution behavior, DNA binding, and anticancer activity
Baidya et al. Synthesis, structure, and properties of potassium bis (L-cysteinato-N, S) nickelate (II) sesquihydrate
Drueke et al. A new tetranuclear oxohydroxoiron (III) cluster: crystal structure, magnetic properties, and EXAFS investigation of [L4Fe4 (. mu.-O) 2 (. mu.-OH) 4] I4. cntdot. 3H2O (L= 1, 4, 7-triazacyclononane)
Lima et al. New mixed ligand oxidovanadium (IV) complexes: Solution behavior, protein interaction and cytotoxicity
Ostrowska et al. Explaining how α-hydroxamate ligands control the formation of Cu (II)-, Ni (II)-, and Zn (II)-containing metallacrowns
Buglyó et al. Interaction between the low molecular mass components of blood serum and the VO (IV)–DHP system (DHP= 1, 2-dimethyl-3-hydroxy-4 (1 H)-pyridinone)
El-Asmy et al. Synthesis, characterization, molecular modeling and eukaryotic DNA degradation of 1-(3, 4-dihydroxybenzylidene) thiosemicarbazide complexes
US5107005A (en) Process to obtain new mixed copper aminoactidate complexes from phenylate phenathrolines to be used as anticancerigenic agents
Duda et al. Co-ordination of copper (II) and nickel (II) ions by a novel open chain oxime ligand
Norin Coordination Chemistry of Novel Drug Candidates for the Treatment of Iron Overload
Griffith et al. Monohydroxamic acids and bridging dihydroxamic acids as chelators to ruthenium (III) and as nitric oxide donors: syntheses, speciation studies and nitric oxide releasing investigation